Biotech Growth Trust PLC - London-based investor in global biotechnology companies - Appoints Nicola Shepherd as independent non-executive director effective from Monday. Says Shepherd is the founder and a director of biomedical translational company Bellows Consulting Ltd. She also has held positions at AstraZeneca PLC in late-stage development and manufacturing, at Brown University in the US, carrying out post-doctoral research into complex formulations, and as a senior member of the Innovations Division at the Wellcome Trust in London, where she was responsible for the establishment, management and oversight of the translation fund.
Current stock price: 1,670.00 pence
Year-to-date change: up 6.0%
By Zoe Wickens; zoewickens@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.


* Targeted therapies drive rising cancer survival rates, experts say


(Alliance News) - AstraZeneca PLC on Tuesday reported encouraging test results for its breast cancer treatment camizestrant.


(Alliance News) - BSF Enterprise on Tuesday saw its shares rise after the publication of a paper on one of its subsidiaries' synthetic leather product...